All the Swiss Startups
Sector: Biotech

Startup Description Support
4-Antibody AG
Basel, 2002
Loading...
4-Antibody is a biopharmaceutical company with a powerful fully-human antibody drug-discovery technology platform.
AB2 Bio SA
Chavannes-Veyron, 2010
Loading...
La société a pour but la recherche, l'étude, le développement, la fabrication, la promotion et la commercialisation de produits et de substances dans le domaine pharmaceutique et nutritionnel.
AC Immune SA
Lausanne, 2003
Loading...
The mission of AC Immune is to identify and develop “best in class” innovative therapies for Alzheimer´s Disease and other conformational diseases.
ADC Therapeutics Sàrl
Saint-Légier-La Chiésaz, 2011
Loading...
Focused on the development of proprietary Antibody Drug Conjugates for the treatment of cancer.
AlloCyte Pharmaceuticals AG
Basel, 2011
Loading...
he company focuses its drug discovery programs on therapeutically validated targets and directs its translational clinical research to indications of high medical need.
Amal Therapeutics SA
Genève 14, 2012
Loading...
Development and progression of a new generation of cancer vaccines
Amphasys AG
Root Längenbold, 2012
Loading...
Single Cell Analysis.
Anergis SA
Epalinges, 2001
Loading...
Anergis develops Breakthrough Allergy Vaccines.
ArenaVax AG
Schlieren, 2010
Loading...
Revolutionary vaccines for unmet medical needs
ArisGen SA
Plan Les Ouates, 2006
Loading...
effective modes of delivery for small molecules and peptides.
Atlas Agro GmbH
Altendorf, 2002
Loading...
Insecticides and fungicides of biological origin.
Ayanda Biosystems SA
Lausanne, 2001
Loading...
Innovative diagnostic and drug discovery tools.
Basiomix Biotech GmbH
Reinach, 2009
Loading...
Efficient and safe subunit drugs.
BELAIR BIOTECH SA
Les Acacias, 2007
Loading...
Providing Unique Biological Solutions for Treating Waste
BioApply Palapas Sàrl
Gland, 2004
Loading...
Market leader for biodegradable retail bags.
BioEqual AG
Muttenz, 2002
Loading...
BioEqual owns patents on substances, able to penetrate skin and nails.
Biognosys AG
Zürich - Schlieren, 2008
Loading...
New standard in multiplexed protein quantification.
Biotechnostics GmbH
Basel, 2012
Loading...
Molecular diagnostic tests for personalized medicine.
BioVersys AG
Basel, 2009
Loading...
Bacterial transcriptional regulators, which initiate bacterial defense mechanisms causing drug resistance.
bioXPRESS Therapeutics SA
Plan-les-Quates, 2008
Loading...
BioXpress Therapeutics SA is a premier provider of high-quality biosimilar biologic APIs for unmet need indications.
Brain & Science SA
Genève, 2011
Loading...
Make better choices for dating and relationships.
C-CIT AG
Wädenswil, 2002
Loading...
C-CIT AG is the innovative sensor specialist for biotechnology, research, environment and frying oil.
Calypso Biotech SA
Plan-les-Ouates, 2013
Loading...
Programs in inflammatory bowel diseases.
Cardiolynx AG
Basel, 2009
Loading...
Therapies for cardiovascular diseases.
Cellec Biotek AG
Basel, 2011
Loading...
Entwicklung, die Herstellung, den Handel und den Vertrieb von analytischen Instrumenten und Geräten.
CELLnTEC Advanced Cell Systems AG
Bern, 2002
Loading...
Innovative culture media, 2D and 3D in vitro models.
ChromaCon AG
Zürich, 2006
Loading...
ChromaCon AG is a biopharmaceutical company providing enabling purification technologies, equipment and services.
Ciliatech Therapeutics AG
Basel, 2011
Loading...
Pharmazeutischen und diagnostische Produkte.
Clariness Holding AG
Zürich, 2006
Loading...
Clariness speeds up clinical trials for its customers in the pharmaceutical industry in order to reduce time to market of newly developed drugs.
CombaGroup SA
Molondin, 2012
Loading...
COMBAGROUP implements a new way of growing lettuce.
Covagen AG
Zürich-Schlieren, 2007
Loading...
Covagen exploits the unique versatility of Fynomers to create next generation biologics.
CovalX AG
Zürich-Schlieren, 2005
Loading...
CovalX Services is providing a direct access to the technology and know-how of the leader in the field of interaction analysis by High-Mass MALDI mass spectrometry.
ct atlantic AG
Schlieren, 2008
Loading...
Novel, human-derived antibodies for the treatment of cancer.
Culture Collection of Switzerland AG
Wädenswil, 2010
Loading...
Culture Collection of Switzerland.
Cytomec GmbH
Spiez, 2005
Loading...
A platform technology for efficient culture of cells on extendable surfaces.
Davos Diagnostics AG
Davos Platz, 2011
Loading...
Development of highly sensitive easy to use low background fast and competitive diagnostic kits for research and health care applications.
Delenex Therapeutics AG
Schlieren-Zurich, 2009
Loading...
Developing therapeutic antibodies against serious medical conditions with high unmet need.
Diagnoplex SA
Lausanne 25, 2005
Loading...
Simplifying colon screening.
DRUGDESIGNTECH SA
Plan les Ouates, 2007
Loading...
drugdesigntech develops innovative computational solutions to support drug discovery.
Dybly AG
Basel, 2006
Loading...
Dybly develops pharmaceutical products for patients affected by the build-up of atherosclerotic plaques.
DynaDes AG
Zürich, 2013
Loading...
Dynamic Drug Design deals with the transfer of novel software technology for drug design
Edimer Biotech SA
Epalinges, 2009
Loading...
Significant and durable improvement in the health and quality of life to future generations affected by the rare genetic disorder, X-linked Hypohidrotic Ectodermal Dysplasia (XLHED).
Ennar Pharma AG
Basel, 2010
Loading...
Entwicklung von Arzneimitteln zur Behandlung von Psoriasis(Schuppenflechte).
Epithelix SA
Plan-les-Ouates, 2006
Loading...
Innovative In Vitro Solutions for Respiratory Diseases and Chemical Testing.
evitria AG
Schlieren, 2010
Loading...
Innovative expression systems design.
Evolva SA
Allschwil, 2004
Loading...
Improving Lives with Synthetic Biology.
ExCellness Biotech SA
Lausanne, 2009
Loading...
Novel surfaces for enhanced cell culture.
Fasteris SA
Plan-les-Ouates, 2003
Loading...
The company provides services for private or academic research laboratories.
Funzyme Biotechnology S.A.
Plan-les-Ouates, 2005
Loading...
Enzyme-based drugs and agents.
Gatlik Ltd.
Basel, 2005
Loading...
Discovery, development and commercialization of innovative treatments.
GeNeuro SA
Plan-les-Ouates, 2006
Loading...
GeNeuro develops a pioneering approach for the therapy and diagnosis of diseases associated with human endogenous retrovirus expression.
GenKyoTex S.A.
Plan-Les-Ouates, 2006
Loading...
GenKyoTex. An Innovative Approach for the Treatment of Pathologies Associated with Overproduction of Oxygen Radicals.
Glycemicon AG
Schwerzenbach, 2013
Loading...
Development of a naturally occurring bile acid as functional food
GlycoVaxyn AG
Schlieren, 2004
Loading...
Development of novel biotechnological methods for the production of glycoconjugates.
gymetrics SA
Ecublens, 2011
Loading...
Captors and measure instruments for biology and pharmaceuticals.
Helvedis Pharma SA
Delémont, 2011
Loading...
Développement,In-licensing, production sous-contract et distribution de produits Pharmaceutiques et Biotechnologiques
Herbonis AG
Basel, 2001
Loading...
Developing and producing natural substances for human and animal health.
Inflamalps SA
Monthey, 2012
Loading...
Développement et commercialisation de médicaments
iNNutriGEL AG
Schlieren, 2005
Loading...
iNNutriGEL owns the exclusive and worldwide rights for all food applications of a series of InnoGEL patents around the starch network technology.
InSphero AG
Schlieren, 2009
Loading...
3D microtissues for drug discovery and cell therapy.
Intrace Medical SA
Lausanne, 2012
Loading...
Relying on breakthrough research in chemical biology Intrace Medical develops markers that reliably identify tissue affected by cancer or bacterial infection in vivo.
Kenta Biotech Ltd.
Bern, 2006
Loading...
Development novel, fully human monoclonal antibodies.
KNLN-Innovation Sàrl
Neuchâtel, 2011
Loading...
KNLN-Innovation développe "Zilooa" des cosmétiques novateurs ménageant l’environnement naturel.
Lascco SA
Genève, 2007
Loading...
LASCCO SA is a biomedical-technology development private company based in Geneva.
Laserix Sàrl
Neuchâtel, 2002
Loading...
Chirurgie du cartilage articulaire
Legacy HealthCare (Switzerland) Sàrl
Epalinges, 2007
Loading...
A breakthrough in Oncology Supportive Care and Dermatology.
LeucoGenics GmbH
Basel, 2009
Loading...
Forschung, Entwicklung und Vermarktung von immun-suppressiven Therapien und Diagnosen.
Lyncée Tec SA
Ecublens VD, 2003
Loading...
For the first time, microscopes combine nanometric resolution, real-time and non-invasive three dimensional observation.
Mabimmune Cardiology AG
Schlieren, 2010
Loading...
Mabimmune aims to prevent myocardial infarction and stroke through early diagnosis and targeted treatment.
Malcisbo AG
Zürich, 2010
Loading...
Platform to identify carbohydrate targets in pathogenic organisms.
Med Discovery SA
Geneva 15, 2002
Loading...
Highly specific treatments for uro-genital cancers.
Medipol SA
Lausanne, 2003
Loading...
Medipol develops next generation immunotherapeutic treatments.
MELCURE SA
Plan-les-Ouates / GE, 2005
Loading...
Novel therapeutics against cancer.
Microbe Investigations AG
Zürich, 2012
Loading...
Microbiological testing.
MicroDuits GmbH
Zürich, 2010
Loading...
Miniaturized laboratory equipment for biological applications.
Mind-NRG SA
Genève, 2010
Loading...
Development of a peptidic neurotrophic factor (NRG-101).
Molecular Partners AG
Zürich-Schlieren , 2004
Loading...
Targeted Protein Therapeutics Beyond Antibodies.
Motilis Medica SA
Lausanne, 2009
Loading...
Innovative pill based technology for diagnosis of the digestive system.
Naviswiss AG
Laufen, 2007
Loading...
Navigation systems for surgeons
NBE-Therapeutics LLC
Basel, 2012
Loading...
Antibody-based NBEs.
Neurimmune Therapeutics AG
Schlieren, 2006
Loading...
Neurimmune is an emerging biotechnology company dedicated to the identification of novel therapeutics for the treatment of human diseases with a focus on neurodegenerative disorders such as Alzheimer’s disease.
Neurotune AG
Schlieren, 2005
Loading...
Neurotune develops medications for neuropathic pain and sarcopenia.
Noorik Biopharmaceuticals AG
Riehen, 2010
Loading...
Noorik intends to develop N-001 for the prevention of Contrast-Induced Acute Kidney Injury.
Novipart Sàrl
Vercorin, 2010
Loading...
Conseil et support efficience organisationnelle et Business development international
Numab AG
Wädenswil, 2011
Loading...
Innovates and develops antibody-based therapeutics.
Obexia AG
Basel, 2009
Loading...
As “the weight switch company” Obexia is focused on important targets in central pathways regulating energy balance.
Oncoethix SA
Lausanne, 2007
Loading...
Defining the clinical potential of promising oncology drug candidates.
Orphanbiotec AG
Zürich, 2009
Loading...
Development and implementation of? new medications for Rare Diseases.
PharmAlp SA
Vercorin, 2011
Loading...
Développement et promotion d'extraits de plantes alpines et de probiotiques dans le domaine de la santé de la femme
Phistem Sàrl
Geneva, 2009
Loading...
Innovative anti-cancer and stem cell therapies.
PhotoDerma SA
Ecublens VD, 2003
Loading...
PhotoDerma SA is a development stage company engaged in research and development of novel cosmetics and pharmaceutics.
Pike Pharma GmbH
Zürich, 2006
Loading...
First-in-class drug candidates against life-threatening viral infections.
PIQUR Therapeutics AG
Basel, 2011
Loading...
The creation of a pharmaceutical spin-off company that develops and commercializes personalized cancer medicines
Plexim GmbH
Zürich, 2002
Loading...
LECS has become the tool of choice for high-speed simulations of power electronic systems.
Preclin Biosystems AG
Epalinges, 2008
Loading...
Your partner in drug validation: in vivo preclinical testing platform.
Prexton Therapeutics SA
Plan les Ouates, 2012
Loading...
Develop innovative drugs to improve the quality of life of people who suffer from Parkinson’s disease and other brain disorders.
Primequal SA
Genève, 2005
Loading...
Safer Faster Injectors.
ProteoMediX AG
Schlieren, 2010
Loading...
Development of markers for the early detection and monitoring of prostate cancer.
QGel SA
Lausanne , 2009
Loading...
A novel hydrogel material.
Qwane Biosciences SA
Lausanne, 2011
Loading...
Qwane Biosciences is commercializing and further developing Micro-Electrode Array (MEA) biochips for basic research in electrophysiology, secondary drug screening and safety pharmacology applications.
Redbiotec AG
Schlieren, 2006
Loading...
Development of new vaccines, including active agents for three different disease areas.
Rootec Bioactives AG
Witterswil, 2007
Loading...
Innovative and flexible technology to produce high-quality plant-derived compounds reliably and at low cost.
rqmicro GmbH
Zürich, 2013
Loading...
Ultra-rapid detection of pathogenic microorganisms in water and food.
Scientis Pharma SA
Carouge, 2010
Loading...
Development of topical Methima-zole
SDK Biotechnologies AG
Landquart, 2010
Loading...
SDK BioTechnologies develops and promotes high-value enabling scientific instrumentation, products and solutions for analyte-detection-related applications in order to facilitate and accelerate laboratory output.
Selexis SA
Plan-les-Ouates, 2001
Loading...
Selexis offers technologies for the rapid development of High Performance of Mammalian Cell Lines useful for discovery/pre-clinical, clinical and commercial production purposes.
Sensecore AG
Zürich, 2008
Loading...
Biomedical monitoring tools in the fields of sport and healthcare.
Sensile Medical AG
Hägendorf, 2004
Loading...
Sensile Medical is a Swiss company that serves as an incubator for innovative and technology driven medical devices.
Sensimed AG
Lausanne, 2003
Loading...
A breakthrough solution to continuously monitor fluctuations of intraocular pressure in glaucoma treatment.
Sophia Genetics SA
Ecublens, 2011
Loading...
Secure storage and analysis of patient genome sequence information.
South Pole Carbon Asset Management Ltd.
Zürich, 2008
Loading...
Marketplace for carbon credits.
Spinomix SA
Ecublens VD, 2004
Loading...
Developing fully automated and miniaturized systems enabling extraction, manipulation and detection of biochemical substances.
Stemergie Biotechnology SA
Geneva, 2009
Loading...
Stemergie Biotechnology SA targets the roots of cancer in developing treatments and diagnostics against brain tumor cancer stem cells (CSCs)
TC Metrix Sàrl
Epalinges, 2012
Loading...
The mission of TCMetrix is to provide researchers in clinical and basic sciences worldwide with innovative, state-of-the-art T cell monitoring reagents of high quality, to meet the increasing needs for conclusive and comprehensive MHC class I and class II T cell monitoring and analysis.
Telormedix SA
Bioggio, 2007
Loading...
Targeted immunity in the treatment of cancer and other diseases.
TransCure Biosciences Holding SA
Genève, 2011
Loading...
TransCure Biosciences (TCB) is providing humanized mice for pharmaceutical companies
Valevia Pharmaceuticals GmbH
Basel, 2009
Loading...
Overcoming Pathogenic Resistance.
Vaxeal Holding SA
Vevey, 2009
Loading...
Vaxeal développe une nouvelle génération de vaccins thérapeutiques
Vaximm AG
Basel, 2008
Loading...
Developing Active Anti-angiogenic Immunotherapies for Cancer Patients.
Viroblock S.A.
Plan-les-Ouates, 2005
Loading...
Developing and commercializing a new generation of anti-viral products
Virometix AG
Zürich, 2009
Loading...
Virometix develops a new generation of vaccines using its Synthetic Virus-Like Particle (SVLP) technology, which enables the creation of a novel type of synthetic nanoparticles.
Zestagen SA
Epalinges, 2011
Loading...
Developing Monolocal Antibodies Agains Metastasis.

PARTNERS